权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Dynamics of Plan Choice and Prescription Drug Utilization in Medicare Part D

医疗保险 D 部分中计划选择和处方药使用的动态

基本信息

批准号：
8896380
负责人：
JONATHAN GRUBER
金额：
$ 31.01万
依托单位：
NATIONAL BUREAU OF ECONOMIC RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-03-15 至 2017-06-30
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): Dynamics of Plan Choice and Prescription Drug Utilization in Medicare Part D. The Medicare Part D prescription drug benefit pioneered the use of multiple private insurance providers to deliver a public insurance product, and as such raises a host of important policy questions. Are consumers capable of making an informed choice across so many private insurance options? Once enrolled in a plan, do consumers respond appropriately to the non-linear schedule of prices they face throughout the year? The key methodological innovation in our work is to construct models where choices reveal information about consumers' preferences, even when those choices are not necessarily optimal. This builds on our earlier work, which uses an incomplete data set to document evidence of inconsistencies in elders' choice of Part D plans. We will replicate and extend this work using a complete 20% sample of Medicare Part D claims provided by CMS. In particular, we will assess whether consumers tend to improve over time as beneficiaries gain experience in the market or whether consumers tend to remain in sub-optimal plans, either because they attempt to choose a better plan and fail, or because they remain in the same plan through inertia. We will develop a structural model which allows us to decompose the demand and supply side factors which drive changes in plan choices over time. Individuals enrolled in Medicare Part D face a complicated dynamic consumption decision: the prices of drugs today depend on out of pocket payments to date. Forward-looking consumers should consider their entire expected path of spending throughout the year in deciding on drug consumption at each point during the year, while time-inconsistent consumers may not do so. We will build a dynamic model of drug consumption with respect to the nonlinear budget sets facing consumers that incorporates uncertainty as well as potential discounting inconsistencies. Changes in drug consumption around the variance in drug plan pricing schedules allow us to identify both whether choices are consistent over time and how individuals react to price uncertainty. We will also extend our analysis to consider the impacts of prescription drug utilization for downstream physician and hospital spending. Our empirical strategy will allow us to estimate both an overall elasticity of hospital and doctor spending with respect to prescription drug expenditures (and coinsurances), and more particular elasticity's for different types of prescription drugs. We can use the results to provide projections of how changes in the time path of prices under Part D (e.g. filling in the donut hole) will impact annual consumption patterns of both prescription drugs and other types of medical consumption.

描述（由申请人提供）：Medicare D 部分中计划选择和处方药使用的动态。Medicare D 部分处方药福利率先使用多个私人保险公司来提供公共保险产品，因此提出了许多重要的政策问题。消费者是否能够在如此众多的私人保险选项中做出明智的选择？一旦加入计划，消费者是否会对他们全年面临的非线性价格表做出适当的反应？我们工作中关键的方法创新是构建模型，其中的选择可以揭示有关消费者偏好的信息，即使这些选择不一定是最优的。这是建立在我们早期工作的基础上的，该工作使用不完整的数据集来记录老年人对 D 部分计划的选择不一致的证据。我们将使用 CMS 提供的 Medicare D 部分索赔的完整 20% 样本来复制和扩展这项工作。特别是，我们将评估消费者是否倾向于随着受益人在市场中获得经验而随着时间的推移而改善，或者消费者是否倾向于保持次优计划，要么是因为他们试图选择更好的计划但失败了，要么是因为他们由于惯性而保持在同一个计划中。我们将开发一个结构模型，使我们能够分解随着时间的推移推动计划选择变化的需求和供给因素。参加 Medicare D 部分的个人面临着复杂的动态消费决策：今天的药品价格取决于迄今为止的自付费用。具有前瞻性的消费者在决定一年中每个时间点的药物消费时应该考虑他们全年的整个预期支出路径，而时间不一致的消费者可能不会这样做。我们将针对消费者面临的非线性预算集建立一个动态的药品消费模型，其中包含不确定性以及潜在的折扣不一致。围绕药物计划定价表差异的药物消费变化使我们能够确定选择是否随着时间的推移保持一致以及个人对价格不确定性的反应。我们还将扩展我们的分析，以考虑处方药使用对下游医生和医院支出的影响。我们的实证策略将使我们能够估计医院和医生支出相对于处方药支出（和共同保险）的总体弹性，以及不同类型处方药的更具体的弹性。我们可以利用这些结果来预测 D 部分下价格时间路径的变化（例如填补甜甜圈洞）将如何影响处方药和其他类型医疗消费的年度消费模式。